AU2018903318A0 - Biomarkers for cancer therapy - Google Patents
Biomarkers for cancer therapyInfo
- Publication number
- AU2018903318A0 AU2018903318A0 AU2018903318A AU2018903318A AU2018903318A0 AU 2018903318 A0 AU2018903318 A0 AU 2018903318A0 AU 2018903318 A AU2018903318 A AU 2018903318A AU 2018903318 A AU2018903318 A AU 2018903318A AU 2018903318 A0 AU2018903318 A0 AU 2018903318A0
- Authority
- AU
- Australia
- Prior art keywords
- biomarkers
- cancer therapy
- cancer
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000090 biomarker Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2019333926A AU2019333926A1 (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
CN201980073086.1A CN113039290A (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer treatment |
EP19858512.7A EP3847282A4 (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
CA3111802A CA3111802A1 (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
PCT/AU2019/050953 WO2020047604A1 (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
KR1020217010250A KR20210057762A (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
US17/274,126 US20210340629A1 (en) | 2018-09-06 | 2019-09-06 | Biomarkers for cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2018903318A0 true AU2018903318A0 (en) | 2018-09-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3651772A4 (en) | Combination cancer therapy | |
EP3836909A4 (en) | Biomarkers for cancer therapy | |
GB201919219D0 (en) | Cancer biomarkers | |
ZA202005847B (en) | Cancer therapy | |
EP3413927A4 (en) | Cancer therapy | |
EP3594365A4 (en) | Biomarker for her2-positive cancer and anti-her2 therapy and use thereof | |
EP3733175A4 (en) | Cancer therapeutic | |
EP3245298A4 (en) | Biomarkers for colorectal cancer related diseases | |
EP3892282A4 (en) | Combination for treating cancer | |
IL282093A (en) | Combination therapy for cancer | |
GB201905780D0 (en) | Cancer therapy | |
EP3713576A4 (en) | Methods for cancer therapy | |
EP3962524A4 (en) | Cancer treatment | |
EP3922251A4 (en) | Cancer immunotheraphy adjuvant | |
EP3576746A4 (en) | Cancer therapeutic | |
EP3894561A4 (en) | Methods for treating cancer | |
EP3439700A4 (en) | Biomarkers for anti-leukemic therapy | |
EP3735255A4 (en) | Chronic car treatment for cancer | |
EP3675891A4 (en) | Combination cancer therapy | |
EP3250708A4 (en) | Biomarkers for colorectal cancer related diseases | |
EP4013896A4 (en) | Proteogenomic methods for diagnosing cancer | |
EP3849310A4 (en) | Combination cancer therapies | |
GB201913957D0 (en) | Cancer | |
GB2580963B (en) | Cancer therapies | |
EP3717003A4 (en) | Gp96-based cancer therapy |